Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - daugybinė mieloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatide - osteoporozė - kalcio homeostazė - sondelbay is indicated in adults. osteoporozės po menopauzės moterims, ir vyrams, kuriems padidėjusi kaulų lūžių rizika. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. gydymo osteoporozės susijusi su ilgalaikis sisteminis gliukokortikoidų terapija moterims ir vyrams padidėjusi rizika lūžis.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

oncopeptides ab - melphalan flufenamide hydrochloride - daugybinė mieloma - antinavikiniai vaistai - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

strides pharma (cyprus) limited - gabapentinas - kietosios kapsulės - 100 mg - gabapentin

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

strides pharma (cyprus) limited - gabapentinas - kietosios kapsulės - 300 mg - gabapentin

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

strides pharma (cyprus) limited - gabapentinas - kietosios kapsulės - 400 mg - gabapentin

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - daugybinė mieloma - antinavikiniai vaistai - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidų vaizdavimas - diagnostikos radiofarmaciniai preparatai - Šis vaistas yra skirtas tik diagnostikai. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.